Wall Street Zen Upgrades SWK (NASDAQ:SWKH) to Buy

Key Points

• SWK has been upgraded from a "hold" to a "buy" rating by Wall Street Zen, indicating a positive outlook for the stock.
• Despite the upgrade, Maxim Group reduced their price target for SWK from $21.00 to $18.00, yet maintained a "buy" rating.
• SWK reported a quarterly earnings per share of $0.38, significantly surpassing the consensus estimate of $0.18, showcasing strong financial performance.

Wall Street Zen upgraded shares of SWK (NASDAQ:SWKH - Free Report) from a hold rating to a buy rating in a research note published on Saturday morning.

Separately, Maxim Group dropped their price objective on shares of SWK from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Monday, May 19th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $18.00.

SWK Trading Up 0.3%

NASDAQ SWKH traded up $0.05 during mid-day trading on Friday, hitting $14.58. The company's stock had a trading volume of 3,376 shares, compared to its average volume of 9,825. The firm has a market capitalization of $177.15 million, a P/E ratio of 10.27 and a beta of 0.16. The stock's fifty day simple moving average is $14.78 and its two-hundred day simple moving average is $15.25. SWK has a 52-week low of $13.17 and a 52-week high of $20.49. The company has a debt-to-equity ratio of 0.13, a current ratio of 3.17 and a quick ratio of 3.17.

SWK (NASDAQ:SWKH - Get Free Report) last posted its quarterly earnings data on Thursday, August 14th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.18 by $0.20. The company had revenue of $10.05 million for the quarter. SWK had a net margin of 39.00% and a return on equity of 8.43%.

Institutional Trading of SWK

A number of hedge funds and other institutional investors have recently made changes to their positions in SWKH. GAMMA Investing LLC boosted its holdings in SWK by 2,955.0% in the first quarter. GAMMA Investing LLC now owns 3,391 shares of the company's stock worth $59,000 after purchasing an additional 3,280 shares during the period. Russell Investments Group Ltd. boosted its holdings in SWK by 139.0% in the first quarter. Russell Investments Group Ltd. now owns 4,065 shares of the company's stock worth $71,000 after purchasing an additional 2,364 shares during the period. Bank of America Corp DE boosted its holdings in SWK by 41.8% in the second quarter. Bank of America Corp DE now owns 5,595 shares of the company's stock worth $82,000 after purchasing an additional 1,649 shares during the period. Rhumbline Advisers boosted its holdings in SWK by 13.3% in the first quarter. Rhumbline Advisers now owns 5,690 shares of the company's stock worth $99,000 after purchasing an additional 666 shares during the period. Finally, State of Wyoming boosted its holdings in SWK by 42.5% in the fourth quarter. State of Wyoming now owns 7,374 shares of the company's stock worth $117,000 after purchasing an additional 2,200 shares during the period. Institutional investors own 99.27% of the company's stock.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.